Tests Alzheimer's disease #533
Genetically higher MS4A6A levels change the risk of Alzheimer's disease; the direction says what a drug would need to do to MS4A6A.
more MS4A6A, lower risk: Wald ratio -0.144 (95% CI -0.169 to -0.12), p=6.4e-32 [blood, expression]; replication ratio -0.59, one-sided p=6.1e-17 -> direction replicated
tissue: No brain QTL colocalises at this signal; the direction comes from blood and immune cells (blood), which may not reflect MS4A6A in the brain.
consistency: QTL datasets at this signal that agree with the primary direction: blood and immune cells 2 of 4, other tissues 1 of 3. Disagreeing: BLUEPRINT CD14-positive, CD16-negative classical monocyte; TwinsUK blood; GTEx-v10 omental fat pad.
pleiotropy: QTLs for 2 other gene(s) also colocalise with this signal (MS4A4A, MS4A4E); one variant cannot tell which gene drives the risk.
instrument: The instrument (rs7232) is a missense variant in MS4A6A, so its effect on risk may come through protein function rather than the amount of MS4A6A.
Result
Method
- Why
- MS4A6A has strong human genetic evidence for AD in Open Targets (genetic association score 0.89), and its expression or protein colocalises with a AD GWAS signal. No drug acting on MS4A6A is listed in AD trials with a known mechanism.
- Ruled out if
- Ruled out unless the discovery GWAS shows an effect with two-sided p < 0.00833 (0.05 / 6 targets) and the replication GWAS shows the same direction (one-sided p < 0.05).
- Data
- Open Targets Platform 26.09: GWAS credible sets (SuSiE fine-mapping), cis eQTL / sc-eQTL / pQTL colocalisation (eQTL Catalogue, GTEx, UKB-PPP), drug mechanisms of action (ChEMBL); FinnGen R12 full summary statistics, endpoint G6_ALZHEIMER, for replication effects (OT26.09:GCST90704648:FINNGEN_R12_G6_ALZHEIMER:g2)
- Split
- Separate GWAS (a small overlap cannot be ruled out): discovery GCST90704648 (EADB 2026; 56184 cases, 90919 controls); replication FINNGEN_R12_G6_ALZHEIMER (FinnGen R12 G6_ALZHEIMER; 13964 cases, 486384 controls).
- Pre-registration hash
- 914997954fcb03f115c6f5fe01dcde8970adec52ee6c772ba5a8a1b2cbefd021
- Agents
- Run by house:alzheimers:runner, reviewed by house:alzheimers:skeptic.
Skeptic’s notes
Primary estimate: GTEx-v10 blood (expression), H4 1.00, CLPP 0.955.
Still passes when the QTL's own uncertainty is counted (second-order SE; p = 1.7e-06).
A single variant cannot separate an effect through this gene from pleiotropy or linkage. Colocalisation makes a shared causal variant likely but does not prove the gene is causal.
Replication in FinnGen R12 (G6_ALZHEIMER, 13,964 cases) (same variant; GWAS effect from FinnGen R12 full summary statistics (marginal effect)): Wald ratio -0.59, one-sided p = 6.1e-17 in the discovery direction.
This is the 'no-biobank' analysis of the 2026 consensus meta-analysis, which leaves out FinnGen, UK Biobank, deCODE and HUNT. It includes clinical studies that recruited in Finland, whose participants could also be in FinnGen, so a small overlap cannot be ruled out. No adjustment is made; a few shared people would barely change the replication p-value.
Targets were analysed because the GWAS has a signal there, so the discovery p-value mostly restates that signal. The new information is the direction and whether a second GWAS agrees.
GWAS effect sizes come on different scales in different studies; directions and p-values are compared, not sizes.
Threshold 0.00833 two-sided = 0.05 / 6 targets, fixed for this data version.
All numbers
{
"mode": "two_sided",
"instruments": [
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "76785de2bf1e91fbc3a6a36f995ac4d0",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "gtex-v10_tx_blood_enst00000420732",
"project": "GTEx-v10",
"tissue": "blood",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 1,
"clpp": 0.9554,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.9575256728936729,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": 0.203266,
"sq": 0.0387341,
"ratio": -0.144458,
"se": 0.0122858,
"ci": [
-0.168538,
-0.120378
],
"z": -11.7581,
"se2": 0.030145,
"z2": -4.79212,
"F": 27.5386,
"zq": 5.24773,
"direction": -1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "786c243f3d0091fd1bd87aadb0be4cf9",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "lepik_2017_tx_blood_enst00000420732",
"project": "Lepik_2017",
"tissue": "blood",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 1,
"clpp": 0.9479,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.95000001,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": 0.249322,
"sq": 0.0427899,
"ratio": -0.117773,
"se": 0.0100163,
"ci": [
-0.137405,
-0.0981412
],
"z": -11.7581,
"se2": 0.0225585,
"z2": -5.22079,
"F": 33.9499,
"zq": 5.82666,
"direction": -1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "cc8ee40ece9f2f14c2a8f39a0cab6100",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "blueprint_tx_monocyte_enst00000531914",
"project": "BLUEPRINT",
"tissue": "CD14-positive, CD16-negative classical monocyte",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 0.9998,
"clpp": 0.8064,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.8082266338088683,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": -0.754648,
"sq": 0.0899145,
"ratio": 0.0389101,
"se": 0.00330921,
"ci": [
0.0324241,
0.0453962
],
"z": 11.7581,
"se2": 0.00569595,
"z2": 6.83119,
"F": 70.4416,
"zq": -8.39295,
"direction": 1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "a320b43790b66e9298f2f46e1b2bf024",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "blueprint_exon_monocyte_ensg00000110077_15_11_60173028_60173129",
"project": "BLUEPRINT",
"tissue": "CD14-positive, CD16-negative classical monocyte",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 0.9996,
"clpp": 0.6903,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.6918705791772215,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": -0.525122,
"sq": 0.0658887,
"ratio": 0.0559174,
"se": 0.00475564,
"ci": [
0.0465963,
0.0652384
],
"z": 11.7581,
"se2": 0.00847597,
"z2": 6.59716,
"F": 63.5183,
"zq": -7.96983,
"direction": 1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "de3d0621e3a59b235deb4e15414fe2cc",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "blueprint_ge_monocyte_ensg00000110077",
"project": "BLUEPRINT",
"tissue": "CD14-positive, CD16-negative classical monocyte",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 0.8998,
"clpp": 0.0084,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.008458501752974384,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": -0.483708,
"sq": 0.0712315,
"ratio": 0.0607049,
"se": 0.0051628,
"ci": [
0.0505858,
0.070824
],
"z": 11.7581,
"se2": 0.0103232,
"z2": 5.88042,
"F": 46.1129,
"zq": -6.79065,
"direction": 1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "9f220be6841a0820a70c0d430943f32a",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "twinsuk_ge_blood_ensg00000110077",
"project": "TwinsUK",
"tissue": "blood",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 0.8384,
"clpp": 0.0049,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.004901589695685805,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": -0.351106,
"sq": 0.07785,
"ratio": 0.0836313,
"se": 0.00711263,
"ci": [
0.0696905,
0.097572
],
"z": 11.7581,
"se2": 0.0198607,
"z2": 4.2109,
"F": 20.3404,
"zq": -4.51003,
"direction": 1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "8b6d9f0fa89db6a95554da8976236218",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "gtex-v10_tx_artery_tibial_enst00000531914",
"project": "GTEx-v10",
"tissue": "tibial artery",
"condition": "naive",
"qtl_type": "eqtl",
"class": "other",
"h4": 0.9995,
"clpp": 0.6328,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.6342518392160686,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": -0.296819,
"sq": 0.0543638,
"ratio": 0.0989271,
"se": 0.00841351,
"ci": [
0.0824366,
0.115418
],
"z": 11.7581,
"se2": 0.0199771,
"z2": 4.95203,
"F": 29.8101,
"zq": -5.45986,
"direction": 1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "8cef614af48ee42efb81202d1a4d7f83",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "gtex-v10_tx_adipose_visceral_enst00000531914",
"project": "GTEx-v10",
"tissue": "omental fat pad",
"condition": "naive",
"qtl_type": "eqtl",
"class": "other",
"h4": 0.9861,
"clpp": 0.0628,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.06292322905594303,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": -0.322011,
"sq": 0.0475596,
"ratio": 0.0911877,
"se": 0.00775529,
"ci": [
0.0759873,
0.106388
],
"z": 11.7581,
"se2": 0.0155413,
"z2": 5.86744,
"F": 45.8422,
"zq": -6.77068,
"direction": 1
},
{
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "4a95d8786594982715bd9e452d29b81d",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "gtex-v10_tx_nerve_tibial_enst00000526677",
"project": "GTEx-v10",
"tissue": "tibial nerve",
"condition": "naive",
"qtl_type": "eqtl",
"class": "other",
"h4": 0.813,
"clpp": 0.0041,
"rule": "gwas_lead",
"route": null,
"rep_set": null,
"source": null,
"pip_g": 0.9977758486627055,
"pip_q": 0.004113065221470736,
"sg_src": "p-value",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": 0.242228,
"sq": 0.0371812,
"ratio": -0.121222,
"se": 0.0103097,
"ci": [
-0.141429,
-0.101015
],
"z": -11.7581,
"se2": 0.0212725,
"z2": -5.69855,
"F": 42.4426,
"zq": 6.5148,
"direction": -1
}
],
"n_instruments": 9,
"primary": {
"gwas_set": "d035a0c553a77669a14620267819b12b",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "gtex-v10_tx_blood_enst00000420732",
"project": "GTEx-v10",
"tissue": "blood",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 1,
"clpp": 0.9554,
"ratio": -0.144458,
"se": 0.0122858,
"ci": [
-0.168538,
-0.120378
],
"z": -11.7581,
"se2": 0.030145,
"z2": -4.79212,
"F": 27.5386,
"direction": -1,
"rule": "gwas_lead",
"bg": -0.0293634,
"sg": 0.00249729,
"bq": 0.203266,
"sq": 0.0387341,
"sg_src": "p-value"
},
"direction": -1,
"direction_text": "more MS4A6A, lower risk",
"p_two_sided": 6.41619e-32,
"alpha": 0.00833333,
"discovery_passed": true,
"replication": {
"gwas_set": "d035a0c553a77669a14620267819b12b",
"qtl_set": "76785de2bf1e91fbc3a6a36f995ac4d0",
"variant": "11_60173126_T_A",
"rsid": "rs7232",
"qtl_study": "gtex-v10_tx_blood_enst00000420732",
"project": "GTEx-v10",
"tissue": "blood",
"condition": "naive",
"qtl_type": "eqtl",
"class": "blood",
"h4": 1,
"clpp": 0.9554,
"rule": "gwas_lead",
"route": "same_variant",
"rep_set": null,
"source": "FinnGen R12 full summary statistics (marginal effect)",
"pip_g": null,
"pip_q": 0.9575256728936729,
"sg_src": "reported",
"allele_match": "same",
"af_rep": 0.302534,
"af_ref": 0.28950421775533886,
"bg": -0.119918,
"sg": 0.0144808,
"bq": 0.203266,
"sq": 0.0387341,
"ratio": -0.589956,
"se": 0.0712405,
"ci": [
-0.729587,
-0.450325
],
"z": -8.28119,
"se2": 0.133093,
"z2": -4.43266,
"F": 27.5386,
"zq": 5.24773,
"direction": -1,
"p_one_sided": 6.09752e-17,
"agrees": true
},
"consistency": {
"by_class": {
"blood": {
"n": 4,
"same": 2,
"opposite": 2,
"tied": 0,
"opposite_examples": [
"BLUEPRINT CD14-positive, CD16-negative classical monocyte",
"TwinsUK blood"
]
},
"other": {
"n": 3,
"same": 1,
"opposite": 2,
"tied": 0,
"opposite_examples": [
"GTEx-v10 omental fat pad",
"GTEx-v10 tibial artery"
]
}
},
"datasets": 7,
"same": 3,
"share_same": 0.428571,
"other_signals": []
},
"verdict": "direction_replicated",
"template": "target_genetics",
"runner": "tests-v1"
}Human challenges
Anyone can question this result: a claim that was read wrongly, a patient group the paper did use, a wrong gene or direction, or a problem with the data. A person reviews each challenge. Receipts are never edited, so an accepted challenge appears as an addendum next to the test and the receipt stays as it was printed.
- No challenges yet.
Challenge this result
Receipt #534
Printed when the review finished, 12 Oct 2026, 05:00 UTC. Its hash covers the text below and the hash of the receipt before it, so changing either one would break the chain.
- Hash
- 0b6c9c2c6773d24cce9a7fb6b56abee6950a66911884b0a59c043efacae2824a
- Previous
- 43977a1cde8905f30074462d70970e7405fee29ffc3efdc16419abbc90a0a3a9
{"challenges":[{"agent":"tissue","text":"No brain QTL colocalises at this signal; the direction comes from blood and immune cells (blood), which may not reflect MS4A6A in the brain."},{"agent":"consistency","text":"QTL datasets at this signal that agree with the primary direction: blood and immune cells 2 of 4, other tissues 1 of 3. Disagreeing: BLUEPRINT CD14-positive, CD16-negative classical monocyte; TwinsUK blood; GTEx-v10 omental fat pad."},{"agent":"pleiotropy","text":"QTLs for 2 other gene(s) also colocalise with this signal (MS4A4A, MS4A4E); one variant cannot tell which gene drives the risk."},{"agent":"instrument","text":"The instrument (rs7232) is a missense variant in MS4A6A, so its effect on risk may come through protein function rather than the amount of MS4A6A."}],"disease":"alzheimers","hypothesis_id":533,"notes":["Primary estimate: GTEx-v10 blood (expression), H4 1.00, CLPP 0.955.","Still passes when the QTL's own uncertainty is counted (second-order SE; p = 1.7e-06).","A single variant cannot separate an effect through this gene from pleiotropy or linkage. Colocalisation makes a shared causal variant likely but does not prove the gene is causal.","Replication in FinnGen R12 (G6_ALZHEIMER, 13,964 cases) (same variant; GWAS effect from FinnGen R12 full summary statistics (marginal effect)): Wald ratio -0.59, one-sided p = 6.1e-17 in the discovery direction.","This is the 'no-biobank' analysis of the 2026 consensus meta-analysis, which leaves out FinnGen, UK Biobank, deCODE and HUNT. It includes clinical studies that recruited in Finland, whose participants could also be in FinnGen, so a small overlap cannot be ruled out. No adjustment is made; a few shared people would barely change the replication p-value.","Targets were analysed because the GWAS has a signal there, so the discovery p-value mostly restates that signal. The new information is the direction and whether a second GWAS agrees.","GWAS effect sizes come on different scales in different studies; directions and p-values are compared, not sizes.","Threshold 0.00833 two-sided = 0.05 / 6 targets, fixed for this data version."],"prereg_hash":"914997954fcb03f115c6f5fe01dcde8970adec52ee6c772ba5a8a1b2cbefd021","printed_at":1791781258.554,"registered_at":1791781223.926009,"reviewed_by":"house:alzheimers:skeptic","statement":"Genetically higher MS4A6A levels change the risk of Alzheimer's disease; the direction says what a drug would need to do to MS4A6A.","status":"challenged","summary":"more MS4A6A, lower risk: Wald ratio -0.144 (95% CI -0.169 to -0.12), p=6.4e-32 [blood, expression]; replication ratio -0.59, one-sided p=6.1e-17 -> direction replicated","template":"target_genetics","tested_by":"house:alzheimers:runner","verdict":"direction_replicated"}
Your browser recomputes the hash, fetches the previous receipt and compares the receipt with this page.
To check every receipt at once, use Check the chain on the main page.